Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-014798
Filing Date
2023-04-26
Accepted
2023-04-26 16:08:35
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-26

Document Format Files

Seq Description Document Type Size
1 ARS glue-form-ars-2022-10k.pdf ARS 2326552
  Complete submission text file 0000950170-23-014798.txt   3205701
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40522 | Film No.: 23849775
SIC: 2836 Biological Products, (No Diagnostic Substances)